BIO-KEY INTERNATIONAL INC (BKYI) Fundamental Analysis & Valuation

NASDAQ:BKYI • US09060C5076

Current stock price

0.463 USD
-0.05 (-9.71%)
At close:
0.4699 USD
+0.01 (+1.49%)
After Hours:

This BKYI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BKYI Profitability Analysis

1.1 Basic Checks

  • BKYI had negative earnings in the past year.
  • In the past year BKYI has reported a negative cash flow from operations.
  • BKYI had negative earnings in each of the past 5 years.
  • In the past 5 years BKYI always reported negative operating cash flow.
BKYI Yearly Net Income VS EBIT VS OCF VS FCFBKYI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

  • With a Return On Assets value of -42.06%, BKYI is not doing good in the industry: 83.46% of the companies in the same industry are doing better.
  • BKYI has a worse Return On Equity (-70.36%) than 75.00% of its industry peers.
Industry RankSector Rank
ROA -42.06%
ROE -70.36%
ROIC N/A
ROA(3y)-114.53%
ROA(5y)-83.12%
ROE(3y)-379.98%
ROE(5y)-244.11%
ROIC(3y)N/A
ROIC(5y)N/A
BKYI Yearly ROA, ROE, ROICBKYI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

  • BKYI has a Gross Margin of 78.40%. This is in the better half of the industry: BKYI outperforms 77.21% of its industry peers.
  • In the last couple of years the Gross Margin of BKYI has grown nicely.
  • The Profit Margin and Operating Margin are not available for BKYI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
BKYI Yearly Profit, Operating, Gross MarginsBKYI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. BKYI Health Analysis

2.1 Basic Checks

  • BKYI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BKYI has more shares outstanding
  • Compared to 5 years ago, BKYI has more shares outstanding
  • Compared to 1 year ago, BKYI has a worse debt to assets ratio.
BKYI Yearly Shares OutstandingBKYI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BKYI Yearly Total Debt VS Total AssetsBKYI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -18.11, we must say that BKYI is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -18.11, BKYI is not doing good in the industry: 93.01% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.22 indicates that BKYI is not too dependend on debt financing.
  • BKYI has a Debt to Equity ratio (0.22) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -18.11
ROIC/WACCN/A
WACC12.26%
BKYI Yearly LT Debt VS Equity VS FCFBKYI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • BKYI has a Current Ratio of 1.26. This is a normal value and indicates that BKYI is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, BKYI is doing worse than 63.60% of the companies in the same industry.
  • BKYI has a Quick Ratio of 1.13. This is a normal value and indicates that BKYI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BKYI (1.13) is worse than 68.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.13
BKYI Yearly Current Assets VS Current LiabilitesBKYI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BKYI Growth Analysis

3.1 Past

  • BKYI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.90%.
  • BKYI shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.38%.
  • The Revenue has been growing slightly by 2.19% on average over the past years.
EPS 1Y (TTM)-61.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.15%
Revenue 1Y (TTM)37.38%
Revenue growth 3Y45.69%
Revenue growth 5Y2.19%
Sales Q2Q%-15.12%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.87% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 11.38% on average over the next years. This is quite good.
EPS Next Y95.17%
EPS Next 2Y37.72%
EPS Next 3Y25.41%
EPS Next 5Y14.87%
Revenue Next Year42.86%
Revenue Next 2Y5.23%
Revenue Next 3Y1.41%
Revenue Next 5Y11.38%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BKYI Yearly Revenue VS EstimatesBKYI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
BKYI Yearly EPS VS EstimatesBKYI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. BKYI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BKYI. In the last year negative earnings were reported.
  • Also next year BKYI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKYI Price Earnings VS Forward Price EarningsBKYI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKYI Per share dataBKYI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

  • BKYI's earnings are expected to grow with 25.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.72%
EPS Next 3Y25.41%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BKYI Dividend Analysis

5.1 Amount

  • BKYI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BKYI Fundamentals: All Metrics, Ratios and Statistics

BIO-KEY INTERNATIONAL INC

NASDAQ:BKYI (4/29/2026, 8:00:01 PM)

After market: 0.4699 +0.01 (+1.49%)

0.463

-0.05 (-9.71%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Industry Strength6.83
Industry Growth87.58
Earnings (Last)03-31
Earnings (Next)05-13
Inst Owners1.57%
Inst Owner Change0%
Ins Owners3.71%
Ins Owner Change0.23%
Market Cap5.02M
Revenue(TTM)7.02M
Net Income(TTM)-4.25M
Analysts82.86
Price Target2.04 (340.6%)
Short Float %1.5%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.63%
Min EPS beat(2)-30.72%
Max EPS beat(2)-22.55%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.88%
Min Revenue beat(2)-15.63%
Max Revenue beat(2)-2.13%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.8
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)-18.36
EYN/A
EPS(NY)-1.9
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.58
BVpS0.56
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -42.06%
ROE -70.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.4%
FCFM N/A
ROA(3y)-114.53%
ROA(5y)-83.12%
ROE(3y)-379.98%
ROE(5y)-244.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.7%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.13
Altman-Z -18.11
F-Score4
WACC12.26%
ROIC/WACCN/A
Cap/Depr(3y)8.01%
Cap/Depr(5y)11.47%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.15%
EPS Next Y95.17%
EPS Next 2Y37.72%
EPS Next 3Y25.41%
EPS Next 5Y14.87%
Revenue 1Y (TTM)37.38%
Revenue growth 3Y45.69%
Revenue growth 5Y2.19%
Sales Q2Q%-15.12%
Revenue Next Year42.86%
Revenue Next 2Y5.23%
Revenue Next 3Y1.41%
Revenue Next 5Y11.38%
EBIT growth 1Y58.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.44%
OCF growth 3YN/A
OCF growth 5YN/A

BIO-KEY INTERNATIONAL INC / BKYI Fundamental Analysis FAQ

What is the fundamental rating for BKYI stock?

ChartMill assigns a fundamental rating of 2 / 10 to BKYI.


What is the valuation status for BKYI stock?

ChartMill assigns a valuation rating of 1 / 10 to BIO-KEY INTERNATIONAL INC (BKYI). This can be considered as Overvalued.


Can you provide the profitability details for BIO-KEY INTERNATIONAL INC?

BIO-KEY INTERNATIONAL INC (BKYI) has a profitability rating of 1 / 10.


What is the earnings growth outlook for BIO-KEY INTERNATIONAL INC?

The Earnings per Share (EPS) of BIO-KEY INTERNATIONAL INC (BKYI) is expected to grow by 95.17% in the next year.